Government ❯ Politics ❯ Regulatory Agencies

FDA

Drug Regulation E-Cigarette Regulation Tobacco Regulation Public Health Drug Policy Abortion Policy Food Safety Drug Advertising Reproductive Rights Drug Approval Commissioner Actions Leadership Issues Leadership Changes

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

The FDA describes an evidence‑driven study now in a data‑gathering phase with no projected timeline.

Missouri, Kansas and Idaho Sue to Block FDA’s New Generic Mifepristone Approval, Curb Mail-Order Access

FDA Approves Second Generic Mifepristone as White House Cites Legal Obligation

FDA Escalates Crackdown on Drug Ads, Moves to Close ‘Adequate Provision’ Loophole